Stock AVCT AVACTA GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Market Closed - London S.E.
Other stock markets
 11:35:29 2024-06-11 am EDT 		5-day change 1st Jan Change
40.75 GBX +0.62% Intraday chart for Avacta Group Plc -3.89% -65.02%
May. 23 Windward wins deal; Kodal progresses at Bougouni AN
May. 23 Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Windward wins deal; Kodal progresses at Bougouni
Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial
AstraZeneca target raised; Antofagasta lowered
Avacta picks Christina Coughlin to replace long-serving CEO
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down
Avacta Group CEO Steps Down; Successor Appointed
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023
Avacta Group plc Announces Chief Executive Officer Changes
First Tin updates Tellerhauser estimates
Avacta Group plc Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 At the AACR Annual Meeting
Avacta doses third patient in drug conjugate trial for tumour tissue
Avacta shareholders give AGM go-ahead to issue new shares
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract
Avacta Group Upsizes Share Placement Amid Strong Investor Demand
Avacta increases placing size to GBP26 million thanks to strong demand
AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise
Avacta plans fundraise to fund clinical development
Avacta says new head of R&D Coughlin brings "deep expertise"
Avacta Group plc Announces Appointment of Christina Coughlin as Head of Research and Development and Resignation of Fiona Mclaughlin as Chief Scientific Officer
Avacta taps biopharma veteran as Therapeutics business chief
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVCT Stock
  4. News Avacta Group Plc
  5. Other languages